Possible Cure for Peanut Allergies in Kids

November 12, 2012

Possible Cure for Peanut Allergies in Kids

Have you been plagued with a peanut allergy all your life? You might be interested in the recent break through in peanut tolerance.

Do your child have a peanut allergy? According to researchers at Duke University Medical Center, They may have a possible cure for peanut allergies in children. A clinical trial was run with 11 children who were sensitive to peanut proteins. This was conducted as a double-blind, placebo-controlled clinical trial where a peanut solution given under the tongue was found to desensitize the children’s peanut allergies. Children received increasing doses of peanut over the period of one year. This particular therapy allowed the children to withstand 20 times more peanut protein than they would be able to without treatment. It is not known at this time whether the lack of sensitivity to their peanut allergy will continue over time.

When you consider all the peanut products on the market as well as other foods processed on equipment that also processes peanuts, a peanut allergy is serious business. If this treatment pans out, that means that parents won’t need to worry about everything their children are eating. This certainly will create a margin of safety that should bring peace of mind.

Sublingual Immunotherapy

This experimental design is known as sublingual immunotherapy which is different from oral immunotherapy. Oral immunotherapy involves eating various foods with increasing dosage to generate the same tolerance. The oral immunotherapy has provided some success with a peanut allergy, however, it is believed that sublingual immunotherapy may be superior.

The new sublingual approach has been previously used on individuals who had allergic rhinitis and asthma with success but had not been used to study food allergies. The peanut allergy therapy definitely looks promising.

Peanut Allergy is Generally for Life

Interestingly, there are more than 3 million individuals in the United States that have peanut or tree nut sensitivities. It is believed that less than 20 percent of these individuals will actually outgrow their allergies. A strong working protocol would be greatly appreciated here. All doctors can do at the moment is to advise a family how to stay away from foods that may contain peanut or pine nut proteins. This is a formidable task that simply can’t work one hundred percent of the time.

It seems that this preliminary trial with sublingual immunotherapy shows great promise for a child that has a peanut allergy. The current trial is continuing forward. Those children who were on sublingual immunotherapy for peanut allergy will continue with treatment for 3 to 4 more years. Those children who received the placebo treatment have entered into the treatment phase. Perhaps this continuation will shed some light on changes in peanut allergy and perhaps even further tolerance to peanut proteins.

Category: Articles